Lung Diseases: all 3,319 studies
Page 23 of 34. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in GreeceCompletedNCT02187926
- Effects of Inspiratory Muscle Training on Breathing Pattern in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02186340Not applicable
- Probiotic Use in Patients With Prior COPD ExacerbationWithdrawnNCT02185092Not applicable
- Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease)TerminatedNCT02182869Phase 2
- Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPDCompletedNCT02182856Phase 4
- A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182674Phase 2
- Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182635Phase 3
- Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02182583Phase 3
- Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177344Phase 3
- Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177318
- Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02177253Phase 3
- Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02176564
- Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT02176200Phase 3
- Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary DiseaseTerminatedNCT02176187Phase 3
- Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02175342Phase 2
- Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed ConditionCompletedNCT02173795Phase 3
- Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02173782Phase 3
- Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)CompletedNCT02173691Phase 3
- Efficacy and Safety of Ba679BR Powder Inhalation in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172807Phase 3
- Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172794Phase 3
- A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat InhalerCompletedNCT02172560
- Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.CompletedNCT02172547
- Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven HyperinflationCompletedNCT02172521
- Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary RehabilitationTerminatedNCT02172508Phase 4
- Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily PracticeCompletedNCT02172495
- Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172482
- Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172469Phase 3
- Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172456Phase 3
- Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary DiseaseCompletedNCT02172443Phase 3
- Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172430Phase 3
- HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172404Phase 3
- Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172391Phase 3
- 12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea ScalesCompletedNCT02172378Phase 3
- Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT02172352Phase 2
- Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172300Phase 3
- Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172287Phase 3
- Heart and Lung Function Monitoring SystemCompletedNCT02168049Not applicable
- Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.TerminatedNCT02168036
- Is COPD a Risk Factor for Cardiovascular Disease?CompletedNCT02162095
- Safety, Tolerability and Preliminary Efficacy of Adipose Derive Stem Cells for Patients With COPDTerminatedNCT02161744Phase 1
- Physical Activity Versus Pulmonary Rehabilitation in COPDCompletedNCT02161393Not applicable
- Impact of "Telecoaching Program" on Physical Activity in Patients With COPDCompletedNCT02158065Not applicable
- Fat Metabolism in OSA and COPDCompletedNCT02157844
- Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and SleepStatus unknownNCT02150616Phase 4
- Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and SleepCompletedNCT02150590Phase 4
- Evaluation of Depression In Chronic Obstructive Pulmonary DiseaseStatus unknownNCT02147912Not applicable
- Personalized Variable Versus Fixed Dose Glucocorticoid Therapy in AECOPDCompletedNCT02147015Not applicable
- Music Therapy in the Treatment of Chronic Obstructive Pulmonary DiseaseCompletedNCT02146235Not applicable
- Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung SurgeryCompletedNCT02146092Phase 2
- Cognitive Status in Chronic Obstructive Pulmonary Disease's PatientsStatus unknownNCT02143700
- Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise PerformanceCompletedNCT02143687Phase 4
- Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise PerformanceCompletedNCT02143609Phase 4
- Modifying Exercise for the COPD PatientCompletedNCT02143206
- The Role of Gastroesophageal Reflux in Scleroderma Pulmonary FibrosisStatus unknownNCT02136394
- Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce ReadmissionsCompletedNCT02135744Not applicable
- Azithromycin for Acute Exacerbations Requiring HospitalizationTerminatedNCT02135354Phase 3
- Efficacy of Inhalation Technique Training.CompletedNCT02131454Not applicable
- Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02128529
- Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung PatientsCompletedNCT02125916Not applicable
- A Micro/Nano Device for Exhaled Breath AnalysisCompletedNCT02123030
- Home-monitoring and Adherence of Patients With COPD to Long-term RehabilitationCompletedNCT02122614Not applicable
- Phenotypes of COPD in Central and Eastern EuropeCompletedNCT02119494
- Is it Necessary to Set External PEEP in AECOPD PatientsCompletedNCT02114567Not applicable
- Downhill Walking Training in COPDStatus unknownNCT02113748Not applicable
- Regional Lung Imaging Using Hyperpolarized Xenon GasCompletedNCT02112929Phase 1
- A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and TherapyTerminatedNCT02111824Phase 1
- Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease PatientsCompletedNCT02108925Not applicable
- Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady StateCompletedNCT02103374Phase 4
- Nutritional Supplementation in Adults With Chronic Respiratory DiseaseCompletedNCT02102009Not applicable
- A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02100332
- Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease PatientsStatus unknownNCT02093195Phase 2
- Endothelial Dysfunction and Chronic Obstructive Pulmonary DiseaseCompletedNCT02092675
- Physical Activity and Self-Efficacy After Pulmonary RehabilitationStatus unknownNCT02086383
- ECCO2R as an Adjunct to NIV in AECOPDCompletedNCT02086084Not applicable
- Early Telemedicine Training in Patients With COPDCompletedNCT02085187Not applicable
- Nitrate Supplementation in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02084758Not applicable
- In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive VentilationCompletedNCT02084043Not applicable
- Efficacy and Physiology of Nasal High Flow TherapyCompletedNCT02083120Not applicable
- Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung DiseaseCompletedNCT02080897
- Balance Training for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02080442
- Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles ComparisonCompletedNCT02076269Phase 1
- Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal StudyCompletedNCT02076061
- Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung DiseaseCompletedNCT02075762Not applicable
- IntellO2 vs Manual Control for Optimizing Oxygenation in InfantsCompletedNCT02074774Not applicable
- A Population-based Investigation of Asthma in the Telemark Region of NorwayActive, not recruitingNCT02073708
- Efficacy of Simvastatin for the Treatment of COPDCompletedNCT02070133Phase 3
- Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPDCompletedNCT02067780Phase 3
- Method To Measure Protein Digestion & AbsorptionCompletedNCT02065141Not applicable
- Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung DiseaseCompletedNCT02060877
- Immunosuppressive Effects of Smoking and HIV-1 on the Development of Lung DiseaseCompletedNCT02058719
- Pilot Study Comparing Different Modes of Non-invasive Ventilation for the Oral Feeding of Preterm InfantsCompletedNCT02055339Not applicable
- Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung DiseaseCompletedNCT02055222
- Effects of Pulmonary Rehabilitation on Respiratory Sounds in Patients With COPDCompletedNCT02050711Not applicable
- Chronic Obstructive Pulmonary Disease Biomarker StudyStatus unknownNCT02050022
- Impact of Family-based Pulmonary Rehabilitation (PR) on Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their Family MembersCompletedNCT02048306Not applicable
- Medical Record Study on Adverse Events Requiring a Higher Level of Care in Flemish HospitalsCompletedNCT02044718
- Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary DiseaseCompletedNCT02042976Not applicable
- Adipose Derived Cells for Chronic Obstructive Pulmonary DiseaseWithdrawnNCT02041000Not applicable
- Evaluation of Long-Acting Muscarinic Antagonists in COPDCompletedNCT02039050Phase 4
- STRETCH OF RESPIRATORY MUSCLES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASECompletedNCT02036762Phase 2/3